Joel Blanchard, PhD
img_Joel Blanchard
ASSISTANT PROFESSOR | Cell, Developmental & Regenerative Biology
Research Topics
Aging, Alzheimer's Disease, Amyotrophic Lateral Sclerosis, Biomechanics/Bioengineering, Biomedical Sciences, Blood-Brain Barrier, Brain, Cell Biology, Cellular Differentiation, Coronavirus, Cytokines, Developmental Biology, Developmental Neurobiology, Differentiation, Drug Design and Discovery, Education, Endothelial Cells, Gene Expressions, Gene Regulation, Gene editing, Genetics, Genomics, Induced pluripotent stem cells, Membranes, Memory, Microbiology, Microglia, Molecular Biology, Myelination, Nanotechnology, Neurobiology, Neurology, Neuroscience, Niemann Pick Disease, RNA, RNA Splicing & Processing, RNA Transport & Localization, Stroke
Multi-Disciplinary Training Area
Development Regeneration and Stem Cells [DRS], Neuroscience [NEU]
Alzheimer's disease and Stem Cell Biology
Joel Blanchard, PhD, is an Investigator in the Black Family Stem Cell Institute, The Ronald Loeb Center for Alzheimer’s Disease, and an Assistant Professor in the Departments of Neuroscience, and Cell, Developmental and Regenerative Biology. He trained in stem cell biology and neuroscience at Harvard University and The Scripps Research Institute and completed post-doctoral studies at MIT. The Blanchard lab aims to develop cutting-edge in vitro models of the human brain. We then apply these models in conjunction with studies on post-mortem human brain tissue to understand and therapeutically target genetic and environmental vulnerabilities to neurodegeneration.

BS, St. Lawrence University

MLA, Harvard University

PhD, Scripps Research Institute


New award

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.

Dr. Blanchard did not report having any of the following types of financial relationships with industry during 2022 and/or 2023: consulting, scientific advisory board, industry-sponsored lectures, service on Board of Directors, participation on industry-sponsored committees, equity ownership valued at greater than 5% of a publicly traded company or any value in a privately held company. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.